Provision of External Evaluation of Pharmaceutical Benefits Advisory Committee (PBAC) and Health Technology Related Submissions For the Department of Health (CHERE)

Project Member(s): Street, D., Hall, J., Cronin, P., Goodall, S., De Abreu Lourenco, R., Church, J., Arora, S., Meshcheriakova, O., Saing, S., Addo, R., Manipis, K., Vargas Parada, C., Thiboonboon, K., Kim, N., Kenny, P., Lewandowska, M.

Funding or Partner Organisation: Department of Health
Department of Health

Start year: 2020

Summary: Note variation to RES16/905 & PRO16-2158 - Original contract $3.3M

Publications:

Viney, R, Goodall, S, De Abreu Lourenco, R, Thomas, M, Addo, R, Saing, S & Kotnala, A Australian Government Department of Health and Aged Care 2022, Review of the discount rate in the PBAC Guidelines - Report, Online.

FOR Codes: Health Economics, Human Pharmaceutical Products, Evaluation of Health Outcomes, Health economics

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.